BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28548127)

  • 1. Mismatch repair deficiency commonly precedes adenoma formation in Lynch Syndrome-Associated colorectal tumorigenesis.
    Sekine S; Mori T; Ogawa R; Tanaka M; Yoshida H; Taniguchi H; Nakajima T; Sugano K; Yoshida T; Kato M; Furukawa E; Ochiai A; Hiraoka N
    Mod Pathol; 2017 Aug; 30(8):1144-1151. PubMed ID: 28548127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three molecular pathways model colorectal carcinogenesis in Lynch syndrome.
    Ahadova A; Gallon R; Gebert J; Ballhausen A; Endris V; Kirchner M; Stenzinger A; Burn J; von Knebel Doeberitz M; Bläker H; Kloor M
    Int J Cancer; 2018 Jul; 143(1):139-150. PubMed ID: 29424427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
    Fennell LJ; Clendenning M; McKeone DM; Jamieson SH; Balachandran S; Borowsky J; Liu J; Kawamata F; Bond CE; Rosty C; Burge ME; Buchanan DD; Leggett BA; Whitehall VLJ
    Fam Cancer; 2018 Jan; 17(1):63-69. PubMed ID: 28573495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients.
    Ferreira AM; Westers H; Sousa S; Wu Y; Niessen RC; Olderode-Berends M; van der Sluis T; Reuvekamp PT; Seruca R; Kleibeuker JH; Hollema H; Sijmons RH; Hofstra RM
    J Pathol; 2009 Sep; 219(1):96-102. PubMed ID: 19521971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA methylation changes and somatic mutations as tumorigenic events in Lynch syndrome-associated adenomas retaining mismatch repair protein expression.
    Mäki-Nevala S; Valo S; Ristimäki A; Sarhadi V; Knuutila S; Nyström M; Renkonen-Sinisalo L; Lepistö A; Mecklin JP; Peltomäki P
    EBioMedicine; 2019 Jan; 39():280-291. PubMed ID: 30578081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Genetics to Histomolecular Characterization: An Insight into Colorectal Carcinogenesis in Lynch Syndrome.
    Lepore Signorile M; Disciglio V; Di Carlo G; Pisani A; Simone C; Ingravallo G
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome.
    Engel C; Ahadova A; Seppälä TT; Aretz S; Bigirwamungu-Bargeman M; Bläker H; Bucksch K; Büttner R; de Vos Tot Nederveen Cappel WT; Endris V; Holinski-Feder E; Holzapfel S; Hüneburg R; Jacobs MAJM; Koornstra JJ; Langers AM; Lepistö A; Morak M; Möslein G; Peltomäki P; Pylvänäinen K; Rahner N; Renkonen-Sinisalo L; Schulmann K; Steinke-Lange V; Stenzinger A; Strassburg CP; van de Meeberg PC; van Kouwen M; van Leerdam M; Vangala DB; Vecht J; Verhulst ML; von Knebel Doeberitz M; Weitz J; Zachariae S; Loeffler M; Mecklin JP; Kloor M; Vasen HF; ;
    Gastroenterology; 2020 Apr; 158(5):1326-1333. PubMed ID: 31926173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Molecular Analysis for Lynch Syndrome Among Adenomas or Colorectal Cancer Within a National Screening Program.
    Goverde A; Wagner A; Bruno MJ; Hofstra RMW; Doukas M; van der Weiden MM; Dubbink HJ; Dinjens WNM; Spaander MCW
    Gastroenterology; 2018 Nov; 155(5):1410-1415. PubMed ID: 30063919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps.
    Yurgelun MB; Goel A; Hornick JL; Sen A; Turgeon DK; Ruffin MT; Marcon NE; Baron JA; Bresalier RS; Syngal S; Brenner DE; Boland CR; Stoffel EM
    Cancer Prev Res (Phila); 2012 Apr; 5(4):574-82. PubMed ID: 22262812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch repair deficiency in Lynch syndrome-associated colorectal adenomas is more prevalent in older patients.
    Tanaka M; Nakajima T; Sugano K; Yoshida T; Taniguchi H; Kanemitsu Y; Nagino M; Sekine S
    Histopathology; 2016 Aug; 69(2):322-8. PubMed ID: 26826556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temozolomide increases the number of mismatch repair-deficient intestinal crypts and accelerates tumorigenesis in a mouse model of Lynch syndrome.
    Wojciechowicz K; Cantelli E; Van Gerwen B; Plug M; Van Der Wal A; Delzenne-Goette E; Song JY; De Vries S; Dekker M; Te Riele H
    Gastroenterology; 2014 Nov; 147(5):1064-72.e5. PubMed ID: 25088490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lynch syndrome and Lynch syndrome mimics: The growing complex landscape of hereditary colon cancer.
    Carethers JM; Stoffel EM
    World J Gastroenterol; 2015 Aug; 21(31):9253-61. PubMed ID: 26309352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA mismatch repair protein deficient non-neoplastic colonic crypts: a novel indicator of Lynch syndrome.
    Pai RK; Dudley B; Karloski E; Brand RE; O'Callaghan N; Rosty C; Buchanan DD; Jenkins MA; Thibodeau SN; French AJ; Lindor NM; Pai RK
    Mod Pathol; 2018 Oct; 31(10):1608-1618. PubMed ID: 29884888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.
    Kloor M; Huth C; Voigt AY; Benner A; Schirmacher P; von Knebel Doeberitz M; Bläker H
    Lancet Oncol; 2012 Jun; 13(6):598-606. PubMed ID: 22552011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.
    Clendenning M; Huang A; Jayasekara H; Lorans M; Preston S; O'Callaghan N; Pope BJ; Macrae FA; Winship IM; Milne RL; Giles GG; English DR; Hopper JL; Win AK; Jenkins MA; Southey MC; Rosty C; Buchanan DD;
    Fam Cancer; 2018 Jan; 17(1):91-100. PubMed ID: 28616688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of mismatch repair deficiency and Lynch syndrome in a cohort of unselected small bowel adenocarcinomas.
    Suerink M; Kilinç G; Terlouw D; Hristova H; Sensuk L; van Egmond D; Farina Sarasqueta A; Langers AMJ; van Wezel T; Morreau H; Nielsen M;
    J Clin Pathol; 2021 Nov; 74(11):724-729. PubMed ID: 33046565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor mutational signatures in sebaceous skin lesions from individuals with Lynch syndrome.
    Georgeson P; Walsh MD; Clendenning M; Daneshvar S; Pope BJ; Mahmood K; Joo JE; Jayasekara H; Jenkins MA; Winship IM; Buchanan DD
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00781. PubMed ID: 31162827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of mutation-specific mismatch repair protein expression in nonneoplastic endometrium of Lynch syndrome patients.
    Wong S; Hui P; Buza N
    Mod Pathol; 2020 Jun; 33(6):1172-1181. PubMed ID: 31932681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APC mutations are common in adenomas but infrequent in adenocarcinomas of the non-ampullary duodenum.
    Ishizu K; Hashimoto T; Naka T; Yatabe Y; Kojima M; Kuwata T; Nonaka S; Oda I; Esaki M; Kudo M; Gotohda N; Yoshida T; Yoshikawa T; Sekine S
    J Gastroenterol; 2021 Nov; 56(11):988-998. PubMed ID: 34514550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial Cancer.
    Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
    Front Immunol; 2019; 10():3023. PubMed ID: 31998307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.